Obstet Gynecol 2010,Aug,01;116(2 Pt 1):440-1; author reply 441; (PMID: 20664408)
Herman, Jonathan;
|
J Clin Oncol 2010,Jan,10;28(2):189-91; (PMID: 19996025)
Stadler, Zsofia K
; Kauff, Noah D;
|
Cancer Prev Res (Phila Pa) 2010,Jan,01;3(1):12-5; (PMID: 20051368)
Iniesta, Maria D
; Chien, Janet
; ... ; Merajver, Sofia D
; [...]This perspective on Bellacosa et al. (beginning on p. 48 in this issue of the journal) discusses the important biology of microscopically normal tissues in carriers of germ-line BRCA1 or BRCA2 mutations. The work of Bellacosa et al. is an important step toward discerning which pathways[...]
|
J Clin Oncol 2009,Dec,10;27(35):5862-4; (PMID: 19858367)
Garber, Judy E
; Golshan, Mehra;
|
J Genet Couns 2009,Dec,01;18(6):527-9; (PMID: 19760496)
Hampel, Heather;
|
Breast Cancer Res 2009,Jan,01;11(6):111; (PMID: 20017885)
Frizzell, Kristine M
; Kraus, W Lee; [...]) inhibitors have been explored as therapeutic agents for the treatment of hereditary breast and ovarian cancers harboring mutations in BRCA1 or BRCA2. In a new study, Inbar-Rozensal and colleagues show that phenanthridine-derived PARP inhibitors promote [...]cell cycle arrest and cell death in breast cancer cells lacking BRCA1 and BRCA2 mutations and prevent the growth of tumors from xenografts of these cells in immunocompromised mice.[...]
|
J Med Genet 2008,Nov,01;45(11):765-6; (PMID: 18978334)
James, P A
; Harris, M
; ... ; Mitchell, G
;
|
J Med Genet 2008,Jul,01;45(7):409-10; (PMID: 18456714)
Hopper, John L
; Dowty, James G
; ... ; Winship, Ingrid
;
|
Cancer 2007,Dec,15;110(12):2819; author reply 2819-20; (PMID: 17969078)
Mahajan, Niraj N;
|
N Engl J Med 2007,Oct,11;357(15):1555; author reply 1556; (PMID: 17928608)
Goodwin, Pamela J
; Phillips, Kelly-Anne
; ... ; West, Dee W
;
|
|
